Page last updated: 2024-10-29

imipramine and Multiple Primary Neoplasms

imipramine has been researched along with Multiple Primary Neoplasms in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"Imipramine (IMI) treatment yielded complete remission of her symptoms for three years."1.29Panic attacks, complex partial seizures, and multiple meningiomas. ( Nickell, PV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nickell, PV1
Johnson, ER1
Jones, MD1
Stewart, JN1

Other Studies

2 other studies available for imipramine and Multiple Primary Neoplasms

ArticleYear
Panic attacks, complex partial seizures, and multiple meningiomas.
    Anxiety, 1994, Volume: 1, Issue:1

    Topics: Adult; Antidepressive Agents, Tricyclic; Cerebral Ventricles; Epilepsy, Complex Partial; Female; Hip

1994
Occurrence of a pheochromocytoma after ingestion of imipramine.
    The Journal of the American Osteopathic Association, 1979, Volume: 78, Issue:5

    Topics: Abdominal Neoplasms; Adult; Humans; Hypertension; Imipramine; Male; Neoplasms, Multiple Primary; Phe

1979